![Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2422995/bin/cuaj1377T2.jpg)
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC
![Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction](https://www.mdpi.com/cancers/cancers-13-03381/article_deploy/html/images/cancers-13-03381-g001.png)
Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction
![Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7f6a812ee1ae1086bcfed087d13c4231caa4fa80/4-Table3-1.png)
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar
![Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data](https://www.mdpi.com/cancers/cancers-15-00261/article_deploy/html/images/cancers-15-00261-g001.png)
Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data
![Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer - Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -](https://onlinelibrary.wiley.com/cms/asset/996705c8-2b61-4e84-a43c-a508f95db426/ntbl003.jpg)
Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) - Murad - 2011 - International Journal of Cancer -
Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity | PLOS ONE
Efficacy of Androgen Deprivation Therapy for Localized Prostate Cancer: Analysis of pT0 Evaluated by Radical Prostatectomy Speci
![Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7f6a812ee1ae1086bcfed087d13c4231caa4fa80/3-Table1-1.png)
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar
![Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708521005811-ga1.jpg)
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
![Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA | Clinical Proteomics | Full Text Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA | Clinical Proteomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12014-019-9234-4/MediaObjects/12014_2019_9234_Fig4_HTML.png)
Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA | Clinical Proteomics | Full Text
![Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-019-02664-3/MediaObjects/345_2019_2664_Fig5_HTML.png)